Skip to content
Clinical Development

[On-Demand Webinar] Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach

  • July 22, 2024

In this webinar, Sr. Director of Clinical Trial Management Jennifer Brown and Advanced Clinical Practitioners Amanda Sylvester, DNP, APRN, CPNP-BC and Prudence King, MSN, APRN, AGPCNP-BC explore innovative strategies to enhance obesity clinical trials and share practical approaches for maximizing patient retention and protecting endpoint integrity.

Expert Panelists:

Jennifer Brown
Sr. Director, Clinical Trial Management, Medpace

Amanda Sylvester,
DNP, APRN, CPNP-BC
Advanced Clinical Practitioner, Medpace

Prudence King,
MSN, APRN, AGPCNP-BC
Advanced Clinical Practitioner, Medpace

The global obesity epidemic continues to rise, presenting a serious public health challenge. Studies show that more than 1 billion people worldwide are classified as obese, with rates doubling among adults, and quadrupling among children and adolescents since 1990. The associated risks — such as cardiovascular diseases, diabetes and certain cancers — underscore the urgent need for effective intervention strategies.

Addressing obesity through the clinical trials of anti-obesity drugs requires innovative, patient-centered approaches. In this webinar, the speakers provide insights improving obesity clinical trial outcomes, with a focus on strategies to maximize patient retention. Additionally, this webinar highlights the importance of endpoint protection to ensure the integrity and reliability of the trial’s results.

Watch this webinar today to learn how maximizing patient retention and protecting endpoint integrity are making a significant impact on the success of obesity clinical trials.


Cutting-Edge Trial Design & Execution in Obesity

The Medpace medicaloperations, and regulatory staff understand the complexities of obesity trials from the perspective of the Sponsor, the clinical investigator, the scientific leader, and the reviewer at the regulatory agencies. Our matured relationships with global thought leaders, investigative sites, the Medpace global ‘flagship’ metabolic site network, and patient advocacy groups, as well as knowledge of effective patient retention strategies, ensure efficient and quality patient enrollment which is key to the success of these programs.

In addition to therapeutically specialized, full-service CRO offerings, Medpace provides comprehensive and fully integrated global central lab services, a bioanalytical lab, an imaging core lab, an ECG core lab, and a Phase I unit. The built-in collaboration and efficiencies of working with a single vendor facilitates a streamlined strategy for executing trials of all sizes and scope.